HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

KT182

monoacylglycerol lipase ABHD6 inhibitor

Also Known As:

4-(3'-(hydroxymethyl)(1,1'-biphenyl)-4-yl)-1H-1,2,3-triazol-1-yl)(2-phenyl-1-piperidinyl)-methanone

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Triazoles: 1533
      - KT182: 1
  - Piperidines: 17
    - KT182: 1

Experts

1.	Bernal-Chico, Ana: 1 article (10/2018)
2.	Brown, J Mark: 1 article (10/2018)
3.	Cipriani, Raffaela: 1 article (10/2018)
4.	Cravatt, Benjamin F: 1 article (10/2018)
5.	Hsu, Ku-Lung: 1 article (10/2018)
6.	Manterola, Andrea: 1 article (10/2018)
7.	Mato, Susana: 1 article (10/2018)
8.	Matute, Carlos: 1 article (10/2018)
9.	Moreno-Rodríguez, Marta: 1 article (10/2018)
10.	Pérez-Samartín, Alberto: 1 article (10/2018)

Related Diseases

1.	Disease Progression 10/01/2018 - "Chronic administration of KT182 was associated to a partial loss of brain CB1 receptor coupling ability, suggesting the engagement of CB1 receptor-mediated mechanisms during the EAE disease progression. "

Related Drugs and Biologics

1.	CB1 Cannabinoid Receptor (CB1 Receptor)